Microbiology remains an essential tool in reducing microbial growth in the manufacture of pharmaceuticals, to detect and eliminate microorganisms that would pose a risk to patients and jeopardise ...
SMi is pleased to have Robert Porzio, Product Manager, Lonza QC Testing Solutions on the Agenda as a featured speaker for the 7 th annual Pharmaceutical Microbiology conference and exhibition.
Interventions involving bacteria or fungi could help to sequester greenhouse gases, create more sustainable products and ...
For years, Jeff Simmons — the president and CEO of the large US pharmaceutical company Elanco — ridiculed a seemingly unlikely target on social media: the plant-based meat industry.
Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...
According to the police, the accused has been identified as 40-year-old Sanjay Kokare. He had three children but was reportedly unhappy with the birth of his third child, a daughter. Mumbai ...
Microbiology is the study of microscopic organisms, such as bacteria, viruses, archaea, fungi and protozoa. This discipline includes fundamental research on the biochemistry, physiology, cell ...
The Vietnam Agar Agar Gum Market is witnessing significant growth, driven by increasing demand from various industries such as food & beverages, pharmaceuticals, microbiology, and cosmetics. This ...
A vial of Botox, sold by AbbVie, is seen next to its packaging in a photo illustration in Manhattan, New York, U.S., December 8, 2021. REUTERS/Andrew Kelly/File Photo Some drugmakers are taking ...
Mar. 18, 2025 — Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist the treatment. The answer to this antimicrobial ...
Healthcare & Pharmaceuticalscategory· March 21, 2025 Alnylam jumps as expanded US approval for heart disease drug fuels growth prospects Alnylam Pharmaceuticals' shares rose more than 10% on ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy.